WallStreetZenWallStreetZen

NASDAQ: AMLX
Amylyx Pharmaceuticals Inc Stock Ownership - Who owns Amylyx Pharmaceuticals?

Insider buying vs selling

Have Amylyx Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Daphne QuimiDirector2024-05-152,250$1.89
$4.25kBuy
Gina MazzarielloChief Legal Officer2024-05-1510,455$1.88
$19.66kSell
Daphne QuimiDirector2024-05-142,750$1.89
$5.18kBuy
Gina MazzarielloChief Legal Officer2024-03-051,540$18.73
$28.84kSell
Justin B. KleeCo-Chief Executive Officer2024-03-054,135$18.73
$77.44kSell
Joshua B. CohenCo-Chief Executive Officer2024-03-054,135$18.73
$77.44kSell
James M. FratesChief Financial Officer2024-03-051,792$18.73
$33.56kSell
Gina MazzarielloChief Legal Officer2024-02-232,838$18.76
$53.23kSell
Patrick D. YeramianChief Medical Officer2024-01-092,812$16.33
$45.91kSell
Joshua B. CohenCo-Chief Executive Officer2024-01-095,841$16.33
$95.37kSell

1 of 2

AMLX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AMLX insiders and whales buy or sell their stock.

AMLX Shareholders

What type of owners hold Amylyx Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Morningside Venture Investments Ltd38.37%26,091,760$52.71MInsider
Isaac Cheng15.33%10,422,228$21.05MInsider
Invest 1. Bv Als8.67%5,895,280$11.91MInsider
Vanguard Group Inc7.86%5,348,139$10.80MInstitution
Blackrock Inc6.58%4,474,722$9.04MInstitution
Joshua B. Cohen4.71%3,202,852$6.47MInsider
Justin B. Klee4.62%3,139,158$6.34MInsider
Goldman Sachs Group Inc4.33%2,943,186$5.95MInstitution
Millennium Management LLC3.63%2,471,455$4.99MInstitution
Dragsa 96 LLC3.38%2,300,000$4.65MInsider

1 of 3

AMLX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AMLX47.51%52.49%Net BuyingNet Selling
CRVS28.60%47.75%Net BuyingNet Buying
XFOR61.33%1.51%Net Selling
ANL0.05%0.00%
IVA9.31%0.00%

Amylyx Pharmaceuticals Stock Ownership FAQ

Who owns Amylyx Pharmaceuticals?

Amylyx Pharmaceuticals (NASDAQ: AMLX) is owned by 72.82% institutional shareholders, 80.43% Amylyx Pharmaceuticals insiders, and 0.00% retail investors. Morningside Venture Investments Ltd is the largest individual Amylyx Pharmaceuticals shareholder, owning 26.09M shares representing 38.37% of the company. Morningside Venture Investments Ltd's Amylyx Pharmaceuticals shares are currently valued at $51.66M.

If you're new to stock investing, here's how to buy Amylyx Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.